Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR
- PMID: 10203482
- PMCID: PMC84768
- DOI: 10.1128/JCM.37.5.1335-1339.1999
Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR
Abstract
We present a PCR procedure for identification of Burkholderia cepacia, Burkholderia multivorans, and Burkholderia vietnamiensis. 16S and 23S ribosomal DNAs (rDNAs) of B. multivorans and B. vietnamiensis were sequenced and aligned with published sequences for definition of species-specific 18-mer oligonucleotide primers. Specific antisense 16S rDNA primers (for B. cepacia, 5'-AGC ACT CCC RCC TCT CAG-3'; for B. multivorans, 5'-AGC ACT CCC GAA TCT CTT-3') and 23S rDNA primers (for B. vietnamiensis, 5'-TCC TAC CAT GCG TGC AA-3') were paired with a general sense primer of 16S rDNAs (5'-AGR GTT YGA TYM TGG CTC AG-3') or with a sense primer of 23S rDNA (5'-CCT TTG GGT CAT CCT GGA-3'). PCR with these primers under optimized conditions is appropriate to specifically and rapidly identify B. multivorans, B. vietnamiensis, and B. cepacia (genomovars I, III, and IV are not discriminated). In comparison with the polyphasic taxonomic analyses presently necessary for species and genomovar identification within the B. cepacia complex, our procedure is more rapid and easier to perform and may contribute to clarifying the clinical significance of individual members of the complex in cystic fibrosis.
References
-
- Andersen D H. Cystic fibrosis of pancreas and its relation to celiac disease: clinical and pathological study. Am J Dis Child. 1938;56:344–399.
-
- Bauernfeind A, Jungwirth R, Schneider I. Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C: American Society for Microbiology; 1998. Comparative susceptibility of Burkholderia cepacia and the new species Burkholderia multivorans to ciprofloxacin, ceftazidime, and meropenem, abstr. E-163; p. 216.
-
- Bauernfeind A, Jungwirth R, Schneider I, Ratjen F. 12th Annual North American Cystic Fibrosis Conference, Montreal, Canada. Somerset, N.J: Wiley-Liss, Inc.; 1998. Activity of new fluoroquinolones against Burkholderia cepacia and Burkholderia multivorans from cystic fibrosis patients, abstr. 420; p. 322.
-
- Bauernfeind A, Przyklenk B. Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis. Behring Inst Mitt. 1997;98:256–261. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous
